Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASR | P41180 | 15/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5310910 | 0.95 | CASR (0.52) | CASRPOLBRXFP1 | |
| SCHEMBL5310310 | 0.93 | CASR (0.50) | CASRPOLBRXFP1 | |
| SCHEMBL5310323 | 0.93 | CASR (0.52) | CASRPOLBRXFP1 | |
| SCHEMBL5313301 | 0.92 | CASR (0.49) | CASRPOLBGAA | |
| SCHEMBL5311393 | 0.92 | CASR (0.50) | CASRPOLBRXFP1 | |
| SCHEMBL5308152 | 0.91 | CASR (0.58) | CASR | |
| SCHEMBL5309926 | 0.91 | CASR (0.49) | CASRRXFP1GAA | |
| SCHEMBL5310145 | 0.91 | CASR (0.51) | CASR | |
| SCHEMBL5309871 | 0.90 | CASR (0.49) | CASRPOLBRXFP1 | |
| SCHEMBL5307948 | 0.90 | CASR (0.49) | CASRPOLBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007044796-A2 | PYRIDAZINONE COMPOUNDS AS CALCILYTICS | NPS PHARMACEUTICALS, INC. (US) | 2007-04-19 | — | — | WO | claimed |
| WO-2007044796-A2 | PYRIDAZINONE COMPOUNDS AS CALCILYTICS | NPS PHARMACEUTICALS, INC. (US) | 2007-04-19 | — | — | WO | disclosed |
| WO-2007044796-A2 | PYRIDAZINONE COMPOUNDS AS CALCILYTICS | NPS PHARMACEUTICALS, INC. (US) | 2007-04-19 | — | — | WO | disclosed |